Generix Group - Third Quarter Revenue 2019 / 2020: +7% of growth
27 Gennaio 2020 - 06:01PM
Generix Group - Third Quarter Revenue 2019 / 2020: +7% of growth
FINANCIAL PRESS RELEASE
Paris, January 27, 2020
Revenue growth for Q3 2019/2020: +7%
Confirmation of the
financial objectives for the fiscal period
Generix Group, Industrial, Logistics and
Retail Ecosystems provider with leading Collaborative SaaS
Solutions issued today its revenues for the third quarter of its
2019/2020 fiscal year.
Continued growth dynamics (+7%)
New historical record for
quarterly revenue (€20.8M)
|
Quarter ended December 31 |
Change |
9 months ended December 31 |
Change |
Unaudited (K€) |
2019 |
2018 |
2019 |
2018 |
SaaS |
8 164 |
7 197 |
13% |
24 417 |
20 588 |
19% |
Maintenance |
4 849 |
4 741 |
2% |
14 514 |
14 193 |
2% |
Licenses |
1 070 |
1 034 |
3% |
2 800 |
3 246 |
-14% |
Software revenues |
14 083 |
12 972 |
9% |
41 731 |
38 027 |
10% |
Consulting
Services |
6 733 |
6 421 |
5% |
18 945 |
18 668 |
1% |
Revenues |
20 816 |
19 393 |
7% |
60 676 |
56 695 |
7% |
With €20.8 million in turnover, a new record
for quarterly revenue, the group showed 7% organic growth over the
past quarter. This increase was driven by a dynamic and strategic
SaaS business (+13%) and was rounded out by improvement in all
other sectors of activity. Leading growth areas for the quarter
were Russia (+37%), North America (+23%) and the Iberian Peninsula
(+16%), in line with the company’s international deployment
strategy.
At end December 2019, Group revenue rose to €60.7M,
corresponding to organic growth of 7%.
New SaaS contracts for Q3: €1 M
|
Quarter ended December 31 |
Var. Q3 2019 vs Q3 2018 |
9 months ended December 31 |
Var. 2019 vs 2018 |
Unaudited (K€) |
2019 |
2018 |
2019 |
2018 |
New SaaS contract signing (ACV*) |
1 002 |
1 242 |
-19% |
2 361 |
3 723 |
-37% |
*New contracts are expressed in ACV (Annual
Contract Value), which emphasizes the average annual complementary
revenue to be generated after implementing these contracts.
Generix Group registered €1M in new contracts
over the last quarter, an improvement as compared to the first two
quarters of the fiscal year that partially makes up for delayed
income.
Confirmation of financial objectives for the fiscal
period
On the basis of the growth dynamics observed
over the past quarter, the Group reiterates its financial goals for
the fiscal year: increase in turnover and an improved EBITDA
rate.
For the long term, Generix Group will continue a
development program that relies on two strategic pillars, which are
the continuous improvement of operational excellence and the
acceleration of international deployment, most notably in North
America.
Next financial press release: April 27, 2020
after the market closes
Publication of turnover for the 2019/2020 fiscal
year
About Generix Group
Generix Group is a
Collaborative Supply Chain expert present in 60 countries, thanks
to its subsidiaries and network of partners. More than 6,000
companies around the world use its SaaS solutions. The group’s 550
employees provide daily support for such customers as Carrefour,
Danone, FM Logistic, Fnac-Darty, Essilor, Ferrero and Geodis in the
digital transformation of their Supply Chain.
Its collaborative platform, Generix
Supply Chain Hub, helps companies to keep the promises
they make to their customers. It combines the capabilities to
execute physical flows, digitalize information flows, manage
collaborative processes and connect companies to all their
partners, in real time.
Generix Supply Chain Hub is
aimed at all players in the Supply Chain: manufacturers, third- and
fourth-party logistics providers (3PL/4PL) and retailers.
www.generixgroup.com
Founded in France in 1990, the company is listed on
the Eurolist market of Euronext Paris, compartment C (ISIN:
FR0010501692). To learn more: www.generixgroup.com
Financial Communication Contacts: Generix Group –
Ludovic Luzza – Chief Financial Officer – Tel.: +33 (0)1 77 45 42
80 – lluzza@generixgroup.comCM-CIC Market Solutions –
Stéphanie Stahr – Tel.: +33 (0)1 53 48 80 57 –
stephanie.stahr@cmcic.fr
- EXT-EN-FINA-CP-CA-Q3-2019-2020